InMed Pharmaceuticals Inc.
INM
$0.88
-$0.01-1.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.15% | -20.46% | -6.34% | -36.79% | -24.60% |
| Total Depreciation and Amortization | -0.23% | -8.95% | -11.54% | -7.97% | -4.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.26% | -49.88% | -56.52% | 46.33% | 46.01% |
| Change in Net Operating Assets | -229.85% | 91.41% | 8.69% | 139.23% | 76.29% |
| Cash from Operations | -1.77% | -13.70% | -11.18% | -6.09% | -15.08% |
| Capital Expenditure | -- | -- | -- | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 100.00% | 100.00% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 722.22% | 94.11% | 152.19% | -16.39% | -72.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -209.42% | -9.99% | -57.22% | 52.95% | 55.64% |
| Cash from Financing | 831.03% | 105.66% | 163.66% | -11.97% | -74.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 157.81% | 424.42% | 292.41% | -45.79% | -218.91% |